Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481052
Status:
COMPLETED
Last Update Posted:
2022-01-18
First Post:
2007-05-31
Brief Title:
Nilotinib as First-line Treatment of Ph CML in Early Chronic Phase
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-31
First Submit QC Date:
May 31 2007
Study First Post Date:
2007-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-03
Last Update Post Date:
2022-01-18
Last Update Post Date Type:
ACTUAL